Evolent Health (EVH) EV/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EV/EBITDA | ? | -4.12 | -5.72 | 43.0 | 66.7 | -166.5 | 52.0 | ||
Changes by years, y/y, % | -98% | +39% | -852% | +55% | -350% | -2.2% |
Evolent Health. EV/EBITDA
Evolent Health. EV/EBITDA, changes, %
Evolent Health (EVH) EV/EBITDA US GAAP (quarter values) |
||||||||
2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
EV/EBITDA | ? | 1 781 | 74.3 | 40.5 | 40.0 | 58.0 | 52.0 | |
Changes by years, y/y, % | +324% | -192% | -137% | -92% | -89% | |||
Changes by quarters, q/q, % | +247% | -96% | -46% | -1% | +45% |